9 Overstated
Elevated androgens in PCOS disrupt brain dopamine and serotonin signaling.
"First of all, the androgens do disrupt the dopamine and serotonin in their brain. That's a fact." (said at 0:51:15)
While animal models of androgen-induced polycystic ovary syndrome (PCOS) demonstrate alterations in hypothalamic monoamines (including dopamine and serotonin) and kisspeptin/GnRH circuitry, describing this as an established 'fact' in humans is an overstatement. Evidence for central dopamine and serotonin disruption by hyperandrogenism stems primarily from preclinical rodent experiments and hypothesized pathways in narrative reviews, and direct confirmation in clinical populations remains unestablished.
- context: Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to th… (Advances in clinical chemistry 2020) · cited 31x in the literature
"Current literature illustrates that neurotransmitters regulate various functions of the body, including reproduction, mood and body weight. Neurotransmitter alteration could be one of the reasons for disturbed GnRH release, consequently directing the ovarian dysfunction in PCOS, since there is plenty evidence for altered catecholamine metabolism and brain serotonin or opioid activity described in PCOS." (abstract, passage verified)
pubmedfull study (doi) - partial: Neurotransmitter and neuromodulator imbalance in kisspeptin/GnRH regulation in rodent mode… (Behavioural brain research 2026)
"The reduction in kisspeptinergic, monoaminergic, and GABAergic neurotransmission in postnatally androgenized rats and mice suggests that pathways regulating reproduction and mood may share underlying neurobiological mechanisms under an androgenic milieu. Whether this signaling is similarly altered in PCOS patients with mental health disorders remains to be determined." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Polycystic ovary syndrome is the leading cause of infertility globally, and an estimated 90% of affected women remain undiagnosed.
"So why is it that the leading cause of infertility on this planet, 90% of women are not diagnosed?" (said at 1:00:25)
The speaker's claim bundles two assertions with key inaccuracies and overstatements: 1) Polycystic ovary syndrome (PCOS) is widely recognized as the leading cause of anovulatory (ovulatory) infertility—accounting for approximately 70% to 90% of anovulatory infertility cases—rather than all global infertility (which encompasses male factors, tubal obstruction, endometriosis, and unexplained causes). 2) The claim that '90% of women are not diagnosed' overstates published epidemiology; community cohort studies and international health organizations (such as the WHO) estimate that roughly 50% to 70% of affected women remain undiagnosed. The speaker appears to have conflated the statistic that PCOS accounts for up to 70–90% of anovulatory infertility cases with the percentage of undiagnosed women.
More than 50% of PCOS patients also have endometriosis.
"I strongly believe that over 50% of PCOS patients also have endometriosis. Over 50%. And I've always said this, if you have a patient with PCOS, think about it. PCOS is already one of the leading causes of infertility. And in my opinion, 50% of them, because I've seen it in my office, have endometriosis. And I have a path report and I've done laparoscopic surgery to prove it." (said at 1:20:24)
While polycystic ovary syndrome (PCOS) and endometriosis can co-occur, published clinical and epidemiological evidence does not support the claim that over 50% of PCOS patients have endometriosis. Studies investigating the coexistence of these conditions report substantially lower rates (typically ranging from under 10% in general cohorts up to ~25-35% in selected tertiary or gynecological imaging cohorts). The speaker's estimate (>50%) appears to reflect surgical referral bias among patients undergoing laparoscopy for pelvic pain or subfertility rather than the true prevalence across the broader PCOS population.
Endometriosis reduces ovarian reserve (egg count) and egg quality.
"Endometriosis is opposite. Endometriosis destroys your egg count and quality." (said at 1:23:12)
The speaker's assertion that endometriosis 'destroys your egg count and quality' is overstated. Regarding ovarian reserve ('egg count'), systematic reviews and meta-analyses show that women with endometriosis (particularly ovarian endometriomas or advanced disease, as well as post-surgical excision) have reduced anti-Müllerian hormone (AMH) levels, lower antral follicle counts (AFC), and fewer oocytes retrieved during assisted reproduction. However, regarding 'egg quality', systematic reviews and meta-analyses evaluating IVF/ICSI outcomes show that functional markers of oocyte quality—including fertilization rates, blastulation rates, and embryo quality—are largely comparable to controls without endometriosis, indicating that oocyte quantity is reduced rather than oocyte quality being destroyed.
- partial: The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI … (Archives of gynecology and obstetrics 2021) · cited 89x in the literature
"Even though women with endometriomas had a reduced number of oocytes and MII oocytes retrieved when compared to women without, no other differences in reproductive outcomes were identified." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Antral follicle count is reduced in the presence of endometriosis: a systematic review and… (Reproductive biomedicine online 2021) · cited 65x in the literature
"These findings demonstrate that endometriosis is associated with reduced AFC and AMH and elevated serum concentrations of FSH, suggesting a reduction in ovarian reserve in patients with endometriosis, especially in those with ovarian endometrioma and advanced stage." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Indirect markers of oocyte quality in patients with ovarian endometriosis undergoing IVF/I… (Reproductive biomedicine online 2024) · cited 11x in the literature
"Thirty-one studies were included in the meta-analysis, showing no significant differences in fertilization (OR 1.10, 95% CI 0.94-1.30), blastulation (OR 0.86, 95% CI 0.64-1.14) and cancellation (OR 1.06, 95% CI 0.78-1.44) rates. However, patients with OMA exhibited significantly lower numbers of total and mature (metaphase II) oocytes retrieved... In conclusion, although the presence of OMA could decrease the oocyte yield in patients undergoing IVF/intracytoplasmic sperm injection, it does not appear to have an adverse impact on oocyte quality." (abstract, results and conclusion, passage verified)
pubmedfull study (doi)
Long-wavelength red and infrared light from sunlight protects mitochondrial function against damage from short-wavelength light.
"the long-wavelength light from sunlight, the so-called red and infrared light, serves as a protective feature against the short-wavelength light." (said at 1:08:57)
The host claims that red and infrared components of sunlight serve as a natural protective mechanism against short-wavelength light damage. While near-infrared light (IRA) is known to interact with the mitochondrial respiratory chain, cellular research shows it can also generate reactive oxygen species and contribute to photodamage depending on fluence and context. Evidence regarding whether solar red/infrared radiation naturally counteracts or protects against UV-induced short-wavelength injury in humans remains largely theoretical, drawn from preliminary in vitro photobiomodulation models, with very few in vivo studies and no epidemiological proof supporting an inherent protective effect in natural sunlight.
- context: Balance between Health Risks and Benefits for Outdoor Workers Exposed to Solar Radiation: … (International journal of environmental research and public health 2020) · cited 47x in the literature
"A growing body of evidence coming from in vitro studies indicates that IRA is involved in cellular reactive oxygen species (ROS) production and may interfere with the respiratory chain in the mitochondria. Moreover, it can modulate gene expression and some metabolic pathways... Consequently, the net effect of the SS is very difficult to predict at different levels of the biological organization, making more difficult the final balance of health risk and benefits (for the skin, eye, immune system, blood pressure, etc.) in a given exposure situation. Moreover, few in vivo studies and no epidemiological data are presently available in this regard." (abstract, results, passage verified)
pubmedfull study (doi)
Taking wild mulberry leaf before a heavy meal blocks carbohydrate absorption from that meal by 40%.
"It has actually um wild mulberry leaf in it, which believe it or not, if you take it before your heaviest meal, it blocks the absorption of carbohydrates in that meal by 40%." (said at 1:33:11)
Mulberry leaf extract (Morus alba) contains active components like 1-deoxynojirimycin (DNJ), which inhibit alpha-glucosidase enzymes and slow carbohydrate digestion and absorption. However, claiming that taking wild mulberry leaf before a meal 'blocks carbohydrate absorption from that meal by 40%' is an overstatement of magnitude. Randomized controlled crossover trials show modest reductions in postprandial glycemic response (incremental area under the curve reduced by roughly 14% to 22%) and modest decreases in starch digestion, rather than blocking 40% of dietary carbohydrate absorption.
- partial: Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normog… (PloS one 2017) · cited 72x in the literature
"The difference in the positive Incremental Area Under the Curve (pIAUC) (glucose (mmol / L x h)) for half, normal and double dose ME compared with placebo was -6.1% (-18.2%, 5.9%; p = 0.316), -14.0% (-26.0%, -2.0%; p = 0.022) and -22.0% (-33.9%, -10.0%; p<0.001) respectively." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Mulberry leaf extract decreases digestion and absorption of starch in healthy subjects-A r… (Advances in medical sciences 2017) · cited 33x in the literature
"The cumulative percentage dose recovery was lower for the mulberry leaf extract test than for the placebo test (median [quartile distribution]: 13.9% [9.9-17.4] vs. 17.2% [13.3-20.6]; p=0.015)... A single dose of mulberry leaf extract taken with a test meal decreases starch digestion and absorption." (abstract, results and conclusions)
pubmedfull study (doi) - partial: A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic E… (Diabetes therapy : research, treatment and education of diabetes and related disorders 2023) · cited 18x in the literature
"Thirty individuals (12 women, mean age 59 years, HbA1c 7.1%, BMI 26.5 kg/m 2) were enrolled and the MLE-based blend relative to the blend without MLE significantly reduced glucose iAUC at 1 h (- 20%, p < 0.0001), 2 h (- 17%, p = 0.0001), and 3 h (- 15%, p = 0.0032)" (abstract, results)
pubmedfull study (doi)
Endometriosis is the leading cause of chronic pelvic pain and the leading cause of infertility in women.
"It's the top cause of chronic pelvic pain in women. It's the leading cause of infertility. Right?" (said at 1:41:30)
The speaker's statement combines two assertions with differing accuracy: 1) Endometriosis as the leading cause of chronic pelvic pain: Supported. Major clinical reviews identify endometriosis as the most common cause of chronic pelvic pain in reproductive-aged women. 2) Endometriosis as the leading cause of infertility: Overstated. While endometriosis is a prominent and frequent contributor to subfertility (present in an estimated 30–50% of infertile women), ovulatory disorders (predominantly polycystic ovary syndrome, or PCOS) represent the single leading cause of female infertility, followed by tubal factors and male factor infertility.
- supports: Endometriosis. (Endocrine reviews 2019) · cited 850x in the literature
"Endometriosis is the most common cause of chronic pelvic pain in women and is associated with infertility." (abstract, results, passage verified)
pubmedfull study (doi) - context: Diagnosis and Management of Infertility: A Review. (JAMA 2021) · cited 1302x in the literature
"The most common causes of infertility are ovulatory dysfunction, male factor infertility, and tubal disease. The remaining 15% of infertile couples have "unexplained infertility." Lifestyle and environmental factors, such as smoking and obesity, can adversely affect fertility. Ovulatory disorders account for approximately 25% of infertility diagnoses; 70% of women with anovulation have polycystic ovary syndrome." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Endometriosis: Epidemiology, Risk Factors, Molecular Mechanisms, Diagnosis, and Management… (MedComm 2026)
"It is a leading cause of chronic pelvic pain, dysmenorrhea, and infertility, imposing a substantial burden on individual health and healthcare systems." (abstract, results, passage verified)
pubmedfull study (doi)
Following laparoscopic surgical excision of endometriosis, post-operative hormonal suppression is required to prevent lesion recurrence.
"Once you go in laparoscopically and cut these lesions out, you have to give it hormonal suppression. Otherwise, it comes back." (said at 1:49:24)
Post-operative hormonal suppression significantly reduces the risk of endometriosis recurrence and symptom relapse following conservative surgery (e.g., meta-analyses show a relative risk of ~0.41 compared to expectant management or placebo). However, claiming that clinicians 'have to' give hormonal suppression and that endometriosis will inevitably return otherwise is an overstatement. Recurrence without hormonal suppression is not universal (baseline recurrence rates typically range from 20% to 40% over several years, not 100%), and hormonal suppression is neither feasible nor recommended for patients attempting immediate post-operative pregnancy.
Giving birth before age 40 reduces the long-term risk of developing breast cancer.
"We know that having children before age 40 is protective against certain cancers, breast cancer in particular." (said at 2:13:57)
Large-scale epidemiological studies confirm that parity and childbearing provide long-term protection against breast cancer, but the protective effect is strongly dependent on an early age at first full-term pregnancy (typically before age 25 to 30). Childbearing for the first time in one's 30s is generally associated with a neutral or even increased risk of breast cancer compared to nulliparity, rather than being protective up to age 40. Furthermore, prospective pooled data show that childbirth causes a transient increase in breast cancer risk that peaks around 5 years postpartum and takes more than 20 years to cross over into long-term protection, with the post-pregnancy risk increase being more pronounced in women who are older at first birth.
- partial: Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epide… (Lancet (London, England) 2002) · cited 1473x in the literature
"The relative risk of breast cancer decreased by 4.3% (95% CI 2.9-5.8; p<0.0001) for every 12 months of breastfeeding in addition to a decrease of 7.0% (5.0-9.0; p<0.0001) for each birth." (abstract, results)
pubmedfull study (doi) - context: Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. (Annals of internal medicine 2019) · cited 140x in the literature
"Compared with nulliparous women, parous women had an HR for breast cancer that peaked about 5 years after birth (HR, 1.80 [95% CI, 1.63 to 1.99]) before decreasing to 0.77 (CI, 0.67 to 0.88) after 34 years. The association crossed over from positive to negative about 24 years after birth. The overall pattern was driven by estrogen receptor (ER)-positive breast cancer; no crossover was seen for ER-negative cancer. Increases in breast cancer risk after childbirth were pronounced when combined with a family history of breast cancer and were greater for women who were older at first birth or who had more births." (abstract, results, passage verified)
pubmedfull study (doi) - context: Assessing the causal and independent impact of parity-related reproductive factors on risk… (BMC medicine 2025) · cited 2x in the literature
"Observational evidence proposes a protective effect of having children and an early first pregnancy on breast cancer development; however, the causality of this association remains uncertain." (abstract, background, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.